Drug details

Glofil-125 (sodium iothalamate i-125 injection solution)

type of

Glofil-125 (sodium iothalamate i-125 injection, solution) is an ionic radiopaque contrast agent indicated for evaluation of glomerular filtration in the diagnosis or monitoring of patients with renal disease.

This drug may have the following side effects:

• There are no reported side effects of Glofil-125.

The following drugs are related to Glofil-125, either as a replacement or used together:

• Aranesp (darbepoetin alfa)
• Auryxia (ferric citrate tablets)
• Eliphos (calcium acetate tablets)
• Invokana (canagliflozin tablets)
• Sensipar (cinacalcet)
• Hectorol Injection (doxercalciferol injection)
• Hectorol (doxercalciferol liquid filled capsule)
• Procrit (epoetin alfa)
• Epogen (epoetin alfa)
• Retacrit (epoetin alfa-epbx injection)
• Parsabiv (etalcalcetide for injection)
• Extraneal (icodextrin peritoneal dialysis solution)
• Feraheme (ferumoxytol injection)
• Triferic AVNU (ferric pyrophosphate citrate injection)
• Triferic (ferric pyrophosphate citrate solution, for addition to bicarbonate concentrate)
• Fosrenol (lanthanum carbonate chewable tablets)
• Jynarque (tolvaptan tablets for oral use)
• Mircera (methoxy polyethylene glycol-epoetin beta)
• Zemplar Capsules (paricalcitol)
• Zemplar (paricalcitol tablets)
• Renagel (sevelamer hcl)
• Renvela (sevelamer carbonate)
• Velphoro (sucroferric oxyhydroxide chewable tablets)